Abstract
Background: Cancer is a genetic disease of somatic cells arising from accumulation of genetic changes, and inhibition of oncogenes and restoration of tumor suppressor genes will be of great benefit for cancer patients. Objective: Microarray technology provides a unique opportunity to identify new molecular targets, and many researchers have applied this technology in studies of hepatocellular carcinoma and have identified candidate genes validated to affect cell growth and, finally, prioritized the therapeutic target genes. Methods: We discuss the different microarray technologies such as gene expression array, copy number analysis, proteomic profiling, and whole-genome epigenetic aberration analysis and their application for the screening of liver cancer targeted genes. Results/conclusion: Here, we review recent innovations and approaches to therapeutic target discovery for liver cancer using microarray technology and present data about the outcome of gene target therapy using monoclonal antibodies in our laboratory.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
